Following the completion of the sale, the director directly owned 43,254 shares of the company’s stock, valued at $1,949,025.24. Following the completion of the transaction, the director owned 25,996 shares of the company’s stock, valued at $1,207,254.24. Insiders sold 433,229 shares of company stock valued at $17,944,799 over the last ninety days. California State Teachers Retirement System purchased a new stake in shares of uniQure in the second quarter valued at $540,000. uniQure Company Profile(Get Free Report)uniQure N.V. is a biotechnology company focused on the development and commercialization of gene therapies for patients with severe medical needs.